Research ArticleOMERACT 11
What Has Been the Effect on Trial Outcome Assessments of a Decade of Patient Participation in OMERACT?
Maarten P.T. de Wit, Tineke A. Abma, Marije S. Koelewijn-van Loon, Sarah Collins and John Kirwan
The Journal of Rheumatology January 2014, 41 (1) 177-184; DOI: https://doi.org/10.3899/jrheum.130816
Maarten P.T. de Wit
From the Department of Medical Humanities, VU Medical Centre, Amsterdam,
The Netherlands; CAPHRI School for Public Health and Primary Care, Department of General Practice, Maastricht University Medical Centre, Maastricht,
The Netherlands; School of Clinical Sciences, University of Bristol, and Academic Rheumatology Unit, Bristol Royal Infirmary, Bristol,
UK.
Tineke A. Abma
Marije S. Koelewijn-van Loon
Sarah Collins
REFERENCES
- 1.↵
- Broerse JEW,
- Bunders JFG
- Broerse JEW,
- Elberse JE,
- Caron-Flinterman JFW,
- Zweekhorst MBM
- 2.↵
- Staley K
- 3.↵
- 4.↵
- 5.↵
- 6.↵
- de Wit MPT,
- Berlo SE,
- Aanerud GJ,
- Aletaha D,
- Bijlsma JW,
- Croucher L,
- et al.
- 7.↵
- Bingham CO 3rd.,
- Alten R,
- de Wit MP
- 8.↵
- 9.↵
- Wells G,
- Anderson J,
- Beaton D,
- Bellamy N,
- Boers M,
- Bombardier C,
- et al.
- 10.↵
- Saag KG
- 11.↵
- 12.↵
- OMERACT
- 12a.↵
- de Wit M,
- Abma T,
- Koelewijn-van Loon M,
- Collins S,
- Kirwan J
- 12b.↵
- 12c.↵
- de Wit M,
- Abma T,
- Koelewijn-Van Loon M,
- Collins S,
- Kirwan J
- 13.↵
- 14.↵
- Stake RE
- 15.↵
- Abma TA,
- Nierse C,
- Widdershoven G
- 16.↵
- Britten N
- 17.↵
- Hsieh HF,
- Shannon SE
- 18.↵
- Barbour RS
- 19.↵
- Kuper A,
- Lingard L,
- Levinson W
- 20.↵
- Kirwan J,
- Heiberg T,
- Hewlett S,
- Hughes R,
- Kvien T,
- Ahlmen M,
- et al.
- 21.↵
- Kirwan JR,
- Hewlett SE,
- Heiberg T,
- Hughes RA,
- Carr M,
- Hehir M,
- et al.
- 22.↵
- Kirwan JR,
- Newman S,
- Tugwell PS,
- Wells GA,
- Hewlett S,
- Idzera L,
- et al.
- 23.↵
- Kirwan JR,
- Ahlmen M,
- de Wit M,
- Heiberg T,
- Hehir M,
- Hewlett S,
- et al.
- 24.↵
- 25.↵
- 26.↵
- 27.↵
- Nikolaus S,
- Bode C,
- Taal E,
- van de Laar MA
- 28.↵
- 29.↵
- Pincus T,
- Sokka T
- 30.↵
- Kirwan JR,
- Hewlett S
- 31.↵
- 32.↵
- Nicklin J,
- Cramp F,
- Kirwan J,
- Greenwood R,
- Urban M,
- Hewlett S
- 33.↵
- 34.↵
- 35.↵
- 36.↵
- 37.↵
- 38.↵
- 39.↵
- 40.↵
- Kjeken I,
- Ziegler C,
- Skrolsvik J,
- Bagge J,
- Smedslund G,
- Tovik A,
- et al.
- 41.↵
- Akerhielm CE
- 42.↵
- Akerhielm CE
- 43.↵
- Hewlett S
- 44.↵
- Stiggelbout AM,
- Weijden TV,
- Wit MP,
- Frosch D,
- Legare F,
- Montori VM,
- et al.
- 45.↵
- 46.↵
- Boers M,
- Strand V,
- Simon L,
- Tugwell P,
- Brooks PM
- 47.↵
- Quest E,
- Aanerud GJ,
- Kaarud S,
- Collins S,
- Leong A,
- Smedeby B,
- et al.
- 48.↵
- Richards P,
- de Wit MPT
- 49.↵
- 50.↵
- 51.↵
- 52.↵
- 53.↵
- Abma TA
- 54.↵
- Schipper K,
- Abma TA
- 55.↵
- 56.↵
- 57.↵
- 58.↵
In this issue
The Journal of Rheumatology
Vol. 41, Issue 1
1 Jan 2014
What Has Been the Effect on Trial Outcome Assessments of a Decade of Patient Participation in OMERACT?
Maarten P.T. de Wit, Tineke A. Abma, Marije S. Koelewijn-van Loon, Sarah Collins, John Kirwan
The Journal of Rheumatology Jan 2014, 41 (1) 177-184; DOI: 10.3899/jrheum.130816